These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 15032590)

  • 21. Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production.
    Bafica A; Scanga CA; Serhan C; Machado F; White S; Sher A; Aliberti J
    J Clin Invest; 2005 Jun; 115(6):1601-6. PubMed ID: 15931391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The α4β1 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung.
    Walrath JR; Silver RF
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):24-30. PubMed ID: 20724551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Macrophage activity in anti-Mycobacterium immunity. II. Direct contact of Mycobacterium tuberculosis with the macrophage].
    Lipińska R
    Pneumonol Pol; 1982 Oct; 50(10):535-9. PubMed ID: 6820496
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical role of AIM2 in Mycobacterium tuberculosis infection.
    Saiga H; Kitada S; Shimada Y; Kamiyama N; Okuyama M; Makino M; Yamamoto M; Takeda K
    Int Immunol; 2012 Oct; 24(10):637-44. PubMed ID: 22695634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
    Kahnert A; Seiler P; Stein M; Bandermann S; Hahnke K; Mollenkopf H; Kaufmann SH
    Eur J Immunol; 2006 Mar; 36(3):631-47. PubMed ID: 16479545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic architecture of tuberculosis resistance in a mouse model of infection.
    Yan BS; Kirby A; Shebzukhov YV; Daly MJ; Kramnik I
    Genes Immun; 2006 Apr; 7(3):201-10. PubMed ID: 16452998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The balance between protective and pathogenic immune responses in the TB-infected lung.
    Orme IM; Robinson RT; Cooper AM
    Nat Immunol; 2015 Jan; 16(1):57-63. PubMed ID: 25521685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity.
    Smith S; Jacobs RF; Wilson CB
    J Pediatr; 1997 Jul; 131(1 Pt 1):16-26. PubMed ID: 9255187
    [No Abstract]   [Full Text] [Related]  

  • 30. A mouse model of the recrudescence of latent tuberculosis in the elderly.
    Orme IM
    Am Rev Respir Dis; 1988 Mar; 137(3):716-8. PubMed ID: 3345049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two tales of the polarizing immune responses: Th1-mediated host-microbe interaction in tuberculosis vs. Th2-driven childhood asthma.
    Palaga T
    Asian Pac J Allergy Immunol; 2014 Jun; 32(2):101-2. PubMed ID: 25003722
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathology of tuberculosis.
    Pratt PC
    Semin Roentgenol; 1979 Jul; 14(3):196-203. PubMed ID: 112687
    [No Abstract]   [Full Text] [Related]  

  • 33. The immunological life cycle of tuberculosis.
    Ernst JD
    Nat Rev Immunol; 2012 Jul; 12(8):581-91. PubMed ID: 22790178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium tuberculosis and its ability to resist immunity.
    Young D; O'Garra A
    Novartis Found Symp; 2007; 281():169-77; discussion 177-80, 208-9. PubMed ID: 17534073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-32: an emerging player in the immune response network against tuberculosis?
    Kundu M; Basu J
    PLoS Med; 2006 Aug; 3(8):e274. PubMed ID: 16903776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets Restrict the Oxidative Burst in Phagocytes and Facilitate Primary Progressive Tuberculosis.
    Scheuermann L; Pei G; Domaszewska T; Zyla J; Oberbeck-Müller D; Bandermann S; Feng Y; Ruiz Moreno JS; Opitz B; Mollenkopf HJ; Kaufmann SHE; Dorhoi A
    Am J Respir Crit Care Med; 2020 Sep; 202(5):730-744. PubMed ID: 32421376
    [No Abstract]   [Full Text] [Related]  

  • 37. Diversity of disease in childhood pulmonary tuberculosis.
    Marais BJ; Donald PR; Gie RP; Schaaf HS; Beyers N
    Ann Trop Paediatr; 2005 Jun; 25(2):79-86. PubMed ID: 15949195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of primary tuberculosis and the mechanisms of protective reactions].
    Sukhanovskiĭ VP
    Pediatriia; 1984 Jul; (7):50-4. PubMed ID: 6435090
    [No Abstract]   [Full Text] [Related]  

  • 39. Differing susceptibilities of mice, guinea pigs and rabbits to Mycobacterium tuberculosis.
    Boom WH; Toossi Z
    Trends Microbiol; 1998 May; 6(5):180-1. PubMed ID: 9614341
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.
    Glatman-Freedman A; Casadevall A
    Clin Microbiol Rev; 1998 Jul; 11(3):514-32. PubMed ID: 9665981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.